InvestorsHub Logo
Followers 3
Posts 75
Boards Moderated 0
Alias Born 09/01/2006

Re: Lojiko post# 25060

Wednesday, 04/15/2009 9:44:35 AM

Wednesday, April 15, 2009 9:44:35 AM

Post# of 52049
Its just a continuation of past events and at a much lower share price.
Cortex seems like such a promising company, its pipeline relatively different than others. There is plenty of more positive research on Ampas out there.
The problem is, what percentage of biotechs fail. Of those, probably some do have viable drugs.
Cortex has had an ever changing pipeline which low impact wise has appeared stronger the last year or two but which may also be stigmitized by the FDA and that may be on the mind of other companies.

high impacts, it doesn't matter at this point, there are new compounds but they carry the same weight as the older ones until they are put through a trial with good results, they are fodder until then.

It seems extremely poor sighted for the company to not have a deal by now, realists, the management is not (unless they have offers and are just relaying offer prices back and forth).
It seems extremely poor given the time from respiratory depression trial results to the current time with no concrete deal.
Is this a 5$+/Share company, based on the pipeline, it would seem so, but management can't expect to get a deal to their expectations and desires when they are still early in the trial phases.

If Cortex is holding out for SA results, if they are not positive, what of the deal process.

Of the current process, if other companies are far along and have tested the compounds, what does that mean if they aren't quick to put an offer up. Are there side effects that we haven't been privileged to know about. If you think otherwise, why do no one hear about the Phase 1,2 trials (especially the negative ones) and other from bigger pharmas

The PR may not be too bad, if actual progress in talks is being made and if positive SA results are identified.

From the past time of the 717debacle and the share price then to now, how on earth can you not strongly entertain the likelihood for the company to go under.
If they do, we the shareholders will get squat, it doesn't matter what anything they have may be worth, it won't equate to anything for us.

If you owned GM right now and you bought them 3 yrs ago for 50/sh, why wouldn't you believe the sky is falling.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News